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y-L-Glutaminyl-4-hydroxybenzene is converted by the 
tyrosinase of the common mushroom, Agaricus bisporus, 
to the toxic, dormancy-inducing metabolite 2-hydroxy-4-
imino-2,5-cyclohexadiene-1-one. Hydroxylation of y-L-
glutaminyl-4-hydroxybenzene by mammalian tyrosinase 
was monitored by determining tritium water release 
from y-L-glutaminyl-[3,5-3H]4-hydroxybenzene and oc-
curred at only 25% of the rate found with tyrosine. The 
dihydroxy product of the hydroxylation reaction, y-L-
glutaminyl-3,4-dihydroxybenzene, was not oxidized by 
the mammalian enzyme. Therefore, oxidation of y-L-
glutaminyl-4-hydroxybenzene to sultbydryl-reactive 
quinones by mammalian tyrosinase is an unlikely expla-
nation for the hair depigmentation and inhibition of 
melanocarcinoma growth observed following adminis-
tration of this compound. 
Cleavage of y-L-glutaminyl-4-hydroxybenzene by y-
glutamyl transpeptidase releasing p-aminophenol was 
demonstrated. p-Aminophenol was an active depigment-
ing and melanocytotoxic compound. N2-Methyl-y-L-glu-
taminyl-4-hydroxybenzene was synthesized, differing 
from y-L-glutaminyl-4-hydroxybenzene only by the pres-
ence of a methylated amide linkage. This chemical mod-
ification resulted in a compound resistant to cleavage by 
y-glutamyl transpeptidase and lacking in melanocyto-
toxic activity. ·y-Glutamyl transpeptidase cleavage is 
proposed as the route for transformation of y-L-glutam-
inyl-4-hydroxybenzene into an active inhibitor of mela-
nocytes. 
y-L-Glutaminyl-4-hydroxybenzene (GHB) has recently been 
investigated as a potential chemotherapeutic agent for mel-
anocarcinoma. Bl6 melanomas implanted in isogenetic mice 
and human melanomas grown in athymic nude mice have 
demonstrated growth inhibition when treated with this com-
pound [1,2]. GHB is the preliminary substrate in a pathway 
catalyzed by the tyrosinase of Agaricus bisporus which results 
in the production of 2-hydroxy-4-imino-2,5-cyclohexadiene-1-
one ("490"), an active metabolic inhibitor (Fig 1). In the mush-
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L-DOPA: L-dihydroxyphenylalanine 
MeGHB: N2-methyl-y-L-glutaminyl-4-hydroxybenzene 
room, this pathway functions to induce a dormant state com-
patible with spore production [3]. GHB is hydroxylated to y-L-
glutaminyl-3,4-dihydroxybenzene (GDHB) by tyrosinase with 
GDHB acting as an electron-donating co-factor in the reaction. 
GDHB is then oxidized by tyrosinase to y-L-glutaminyl-3 4-
benzoquinone (GBQ) [ 4]. GBQ undergoes a base-catalyzed n;n-
enzymatic cleavage reaction to yield "490" [5]. Exposure of 
bacteria and mammalian cell lines in vitro to "490" resulted in 
cytostatic and cytocidal responses [6,7]. "490" acts as a sulfhy-
dryl reagent, inhibiting many enzymes involved in normal en-
ergy metabolism [8], as well as DNA polymerase a from calf 
thymus and murine leukemia L1210 cells [9,10]. 
The response observed from treatme.nt of melanocarcinoma 
with GHB has been ascribed to activation of this compound by 
mammalian tyrosinase. Toxic "490" results from GHB by the 
action of tyrosinase in the mushroom and a similar transfor-
mation of GHB has been proposed for mammalian cells which 
contain this enzyme [2]. However, the mushroom and mam-
malian tyrosinases are very different. The mushroom enzyme 
has been purified and well characterized [11]. The mammalian 
enzyme, on the other hand, is membrane-bound and only poorly 
understood [12]. Indeed, controversy exists about whether a 
sing le mammalian enzyme performs both the hydroxylation 
and oxidation reactions [13]. The substrate specificity of mush-
room tyrosinase is very broad, while the mammalian enzyme 
requires compounds very similar in structure to its natural 
substrates, L-tyrosine and L-dihydroxyphenylalanine (L-
DOPA) [14-16]. On this basis alone, GHB would appear to be 
an unlikely substrate for mammalian tyrosinase. In addition to 
showing growth inhibition of melanocarcinomas in vivo, GHB 
functions as a depigmenting agent. The hair of C57 black mice 
treated with GHB tumed white [1] and microscopic examina-
tion of the hair follicles of these animals showed selective lysis 
of melanocytes [17]. Many other agents have been identified 
which exhibit specific melanocytotoxicity [18,19]. These com-
pounds are of diverse structw-e, so that tyrosinase activation 
per se seems an unlikely explanation for their depigmentary 
properties. 
A structw-e-function study of GHB and its analogues showed 
that activity was dependent upon an intact y-glutamyl side 
chain [20]. y-Glutamyl transpeptidase (GGTP) is an enzyme 
found in many mammalian tissues [21]. GGTP acts specifically 
on y-glutamyl compounds, cleaving the amide linkage with 
transfer to an amino acid acceptor or water [22]. If GHB were 
a GGTP substrate, a product of the reaction would be p-
aminophenol, a compound structurally and chemically similru-
to many of the known depigmenting agents. 
In this study, we utilized y-L-glutaminyi-[3,5,-3H]4-hydroxy-
benzene ([3,5-3H]GHB) to investigate GHB as a substrate for 
mammalian tyrosinase. GDHB and L-DOPA were compal"ed as 
co-factors in the hydroxylation of GHB. The oxidations of 
GDHB and L-DOPA by mammalian tyrosinase were studied 
spectrophotometrically. GHB was shown to be a good substrate 
for GGTP, and the depigmenting activity of p-aminophenol 
was verified. N 2-Methyl-y-L-glutaminyl-4-hydroxybenzene 
(MeGHB) , a newly synthesized compound, was shown to be 
resistant to cleavage by GGTP and to be lacking in melanocy-
totoxic activity.The mechanism of the melanocyte-specific tox-
icity of GHB is therefore proposed to be related to its cleavage 
by GGTP and to the production of p -aminophenol. 
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FIG 1. The reactions catalyzed by the tyrosinase of A. bisporus 
r esulting in the metabolic activa tion of GHB to the sulfhydryl reagent 
"490". GHB is hydroxylated to GDHB and GDHB is oxidized to GBQ 
by tyrosinase. GBQ undergoes a base-catalyzed nonenzymatic reaction 
to yield "490". 
MATERIALS AND METHODS 
The syntheses of GHB, GDHB and [3,5-"H]GHB have been de-
scribed [4]. [3,5-'1H]tyrosine was obtained fTOIJI New England Nuclear, 
Boston, Mass. Crude porcine kidney GGTP and y-L-glutamyl-4-ni-
t roaniline were obtained from Sigma Chemical Co., St. Louis, Mo. p -
Aminophenol was obtained from Aldrich Chemical Co., Milwaukee, 
Wis. 
M elting points were acquired on a Thomas-Hoover Uni-melt appa-
ratus. Eastman 0.16 mm cellulose and 0.25 mm silica gel F-254 plates 
were used for thin-layer chromatography. A JOEL MH-100 was used 
for 1H NMR. A Beckman DU spectrophotometer with Gilford acces-
sories or a Cary 219 spectrophotometer was used to follow the oxidation 
of catechols. Scintillation counting was performed with a Beckman LS-
150 Scintillation Spectrometer using Aquasol-2 scin ti llation fluid (New 
England Nuclear) with reaction samples processed as previously de-
scribed [ 4,23]. 
Synthesis of M eGHB 
(S)-3-Benzyloxycarbonyl-5-oxo-4-oxazolidinepropionic acid [24] was 
stirred at oac in tetrahydrofuran with 1 equivalent of ethyl chlorofor-
mate and 2 equivalents of triethylamine. After warming to room tem-
perature, 1 equivalent of N-methyl-p -aminophenol (as the sulfa te salt, 
Aldrich) was added. After stirring for 4 hr, the reaction solution 
contain ing coupled product was filtered and the tetrahydrofuran re-
moved in vacuo. The residue was dissolved in chloroform, extracted 
with 5% sodium bicarbona te, 1 N HCI and saturated sodium chloride; 
t h e chloroform layer was dried over sodium sulfate and then taken to 
dryness in. vacuo. Yield was 88% and the product gave a characte ristic 
1H NMR spectrum. Thin-layer chromatography on silica gel with 
eth er/ethyl acetate (6:1) gave one spot, Rr = 0.40. The cyclic protecting 
group was removed with aqueous sodium hydroxide in methanol and 
tetrahydrofuran. Following adjustment to pH 4, solvent was removed 
under reduced pressure and the residue dissolved in ethyl acetate. After 
drying over sodium sulfate, the solvent was removed in vacuo. The 
product, N-benzyloxycarbonyi-N2-methyl-y-L-glutaminyl-4-hydroxy-
benzene, was identified by 1H NMR and gave one spot on silica gel 
t hin-layer chromatography with chloroform/ methanol (5:1) , Rr = 0.25. 
Yield was 100%. The benzyloxycarbonyl protecting group was removed 
by hyd.rogenolysis in methanol and acetic acid with 5% Pd./ C. Following 
filtration and removal of the solvent, the residue was dissolved in 
methanol and the product precipita ted with acetone and tetrahyw·o-
furan . Yield was 91%. Cellulose thin- layer chxomatography with bu-
tanol/water/ pyridine/ acetic acid (15:12:10:3) gave one ninhydrin posi-
tive spot, Rr = 0.66. The structw·e of the product, N2-methyl-y-L-
glutaminyl-4-hydxoxybenzene, was verilled by 1H NMR m.p. = 205-
2070C (decomposition) . 
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Melanoma 
A deeply pigmented variant of murine Bl6 melanoma was kindly 
provided to us by Dr. Funan Hu, Depar tment of Cutaneous Biology, 
Oregon Regional Primate Reseru·ch Center, Beaverton, Oregon. The 
characteristics of this cell line have been described [25,26]. The tumor 
was maintained by serial subcuta neous passage of 1 mm·1 fragments to 
the right flank of C57Bl/6J mice (The J ackson Laboratory, Bru· Harbor, 
Mame) and remained uniformly heavily pigmented th1·oughout 3 yr of 
continuous t ransfer. Tumors of l em~ were obtained 2-3 weeks after 
transplantation. Following cervical dislocation, tumors were removed 
from the mice and melanosome prepru·ation was begun. AU melanosome 
prepru·ation procedures were carried out at 0-4 °C [27,28]. The protein 
concentration in the crude melanosome prepru·ation was determined by 
the method of Lowry et at [29]. Centrifugations were performed using 
a Beckman Model L Ultracentrifuge with a Type 65 rotor. 
Assay of GGTP Activity 
GGTP activity was assayed as described by Tate and Meister [22]. 
Crude porcine kidney GGTP was added to substrate present in buffer 
at pH 8.0 of 50 mM Tris-HCI, 75 mM NaCl and 50 mM glycylglycin e at 
30°C. Cleavage of substrates was followed spectrophotometri~ally by 
observing the apperu·ance of the chromophore of the cleavage product: 
p -nitroaniline, E4o5 = 9000 M- ' cm- 1; p -aminophenol, e294 = 1995 M- 1 
em- •. By substracting the molru· extinction coefficient of MeGHB at 
300_ nm, a !le3oo = 1844 M- 1 em- • was determined for N-methyl p-
ammophenol. 
Toxicit.y ofp -aminophenol and MeCHE 
Five-week-old C57BI/6J mice were injected with 50 (1 mouse), 100 
(2) , 200 (1) and 400 (1) mg/kg p-aminophenol in water for clinical 
observation of hair depigmentation. Ten C57Bl/6J mice at 7 days of 
age were given subcutaneous injections of p-aminophenol (400 mg/ kg) . 
Two were observed clinically for 2 mo, while groups of 2 mice were 
sacrificed at 12, 24, 48, and 96 lu· and skin from the head prepared for 
microscopy as described previously [17]. 
Similarly, C57BI/6J mice 4 to 5 days of age were injected subcuta-
neously with MeGHB in water and observed for gross loss of pigmen-
tation. One was given a single dose of 800 mg/ kg, 2 a single injection of 
400 mg/ kg, and 2 were given 3 successive daily injections at 400 mg/ kg. 
For histologic studies, 2 animals were sacrifi ced 12 hr after subcuta-
neous injection of MeGHB at 800 mg/ kg. 
RESULTS 
Hydroxylation of GHB by Mammalian Tyrosinase 
H ydroxylation of a monophenol by tyrosinase yields a di-
phenol and water as a by-product. Using a n appropriately 
tritium labeled substrate, t h e hydroxylation reaction can t h ere-
fore be followed by measuring the apperu·ance of tritium water 
in the reaction solution . Both [3,5-3H ]tyrosine and [3,5-3H]GHB 
have previous ly been used to observe t h e h ydroxylation reac-
tion catalyzed by tyrosinase [ 4,30]. These labeled compounds 
provided a conve nient m eans of compru·ing t h e reactivity of 
mammalian tyrosinase with its natmal substrate tyrosine a nd 
the mushroom phenol GHB. 
A crude melanosom e preparat ion [28] from h eavily pig-
m e nted Bl6 m elanoma was reacted with labeled tyrosine or 
labeled GHB in the presence of co-factor L-DOPA as sh own in 
the Table. After 4 hr, hydroxylat ion by the mela nosome prep-
ru·ation of tyrosine was 4 times that found with GHB (following 
subtraction of the background rate of label release observed 
with a h eat-inactivated prepar ation) . Tritium water release in 
this type of experime nt could resul t from (1) t h e hydroxylating 
activity of m ammalia n tyrosinase [12], (2) the action of a 
peroxidase (31], and (3) t h e nonenzymatic reaction of labeled 
substrate with "activated oxygen" (superoxide, h ydrogen per-
oxide, hydToxyl radical) [32). " Activa.ted oxygen," eith er to 
supply peroxidase or to function in non en zym atic hydroxyl-
ation, could arise from the a utoxidation oftyr osinase substrates 
a nd products. In the analogous catech ola mine series of com-
pounds, autoxidation of epineplu-ine produced superoxide only 
at basic pH [33), while autoxidation of 6- hydroxydopamine at 
neutral pH actively formed superoxide [34]. One might an t ici-
pate, then, that autoxidation of the diphenols L-DOPA and 
GDHB would not generate s ignificant superoxid e under t h e 
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TABLE 3HOH release by tyrosinase-catalyzed hydroxylation of 
tyrosine and GHB 
Time 
Hours 
0 
4 
Tyrosine GHB 
Boiled en-
zyme 
0 
3.2 
Active en-
zyme 
Boiled en-
zyme 
nmoles 3HOH released 
Acti ve en-
zyme 
0 0 0 
5~ 4~ 
31.7 3.2 10.4 
Fresh subcutaneous nodules of pigmented Bl6 melanoma were dis-
rupted by glass-glass homogenization in water and then centrifuged at 
600 xg. The supernatant was centrifuged at 11,000 xg, the pellet 
resuspended in water and recentrifuged at 11,000 Xg. The pellet was 
then suspended in water [28]. Tyrosine or GHB and L-DOPA were 
reacted with active or heat-inactivated (by boiling for 15 min) mela-
noma preparation at 22°C. Monophenol was present at 0.5 mM and L-
DOPA at 50 J.LM in 5 mM sodium phosphate buffer, pH 7.2. Crude 
melanosomal protein was present in the reaction solutions at a final 
concentration of 0.68 mg/ mL Aliquots of 0.5 ml were withdrawn at 0, 1 
and 4 hr and tritium water release was assessed by separation on Dowex 
[23]. Activity is expressed as nmoles tritium water (1HOH) released in 
the reaction volume of 2.0 mi. Tritium label was present at 5.1-8.7 
dpm/ pmol. 
conditions of these experiments. However, the autoxidation of 
products of the tyrosinase pathway, for example the oxidation 
of leukodopachrome to dopachrome, could be a significant 
source of "activated oxygen." 
In the crude melanosome preparation hydroxylating tyrosine 
and GHB, a preference was shown for tyrosine as a substrate. 
Hydroxylation by the action of a peroxidase or by nonenzymatic 
reaction with "activated oxygen" would, if anything, favor GHB 
as a substrate since GHB is more easily oxidized than tyrosine 
[ 4). This observation suggests that at least some of the tritium 
water release from tyrosine can be ascribed to enzymatic catal-
ysis of the hydroxylation reaction by mammalian tyrosinase. 
The hydroxylation reaction catalyzed by tyrosinase requires 
a facile electron-d.onating co-factor. The dihydroxy product of 
the hydroxyla tion reaction normally functions as this co-factor. 
Thus, 1-DOPA is the natural co-factor for tyrosine in mam-
malian cells while GDHB is the co-factor for GHB in the 
mushroom [ 4,35). Tritium water release from [3,5-3H]GHB was 
determined in the presence of the potential electron-donating 
co-factors L-DOPA and GDHB (Fig 2). Only in the presence of 
an active melanosome preparation with the natural mammalian 
co-factor L-DOPA was tritium water release observed. GDHB 
was not an electron-donating co-factor for GHB in the mam-
malian system, indicating that hydroxylation did not occur by 
reaction with "activated oxygen" derived from the autoxidation 
of GDHB to GBQ. Since the autoxidation of GDHB occurs 
more readily than that of L-DOPA, we concluded that the 
autoxidation of 1-DOPA to dopaquinone made little contribu-
tion to nonspecific hydroxylation. Whether the tritium water 
release from [3,5-3H]GHB resulted from hydroxylation by 
mammalian tyrosinase with 1-DOPA acting as co-factor or 
from non-specific reaction with "activated oxygen" derived 
from the autoxidation of intermediates in melanin formation 
(for example, oxidation of leukodopachrome to dopachrome) 
could not be determined. 
These results demonstrated that tyrosine was a better sub-
strate for mammalian tyrosinase than GHB. Some tritium 
water release from [3,5-3H]GHB was observed, but whether or 
not this could be assigned to hydroxylation by mammalian 
tyrosinase remained undefined. 
Oxidation of L-DOPA and GDHB by Mammalian 
Tyrosinase 
The reaction of 1-DOPA with mammalian tyrosinase results 
in the formation of oxidized intermediates en route to the 
production of melanin; the quinone intermediates and poly-
meric melanin-like compounds characteristically absorb visible 
light (36). Similarly, the oxidation of GDHB by mushroom 
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tyrosinase results in the appearance of products absorbing at 
visible wavelengths [10,37). 
Purified melanosomes [27], active and heat-inactivated, were 
incubated for 45 min at 37°C with 1.0 mM L-DOPA or 1.0 mM 
GDHB. The active melanosome preparation with 1 -DOP A 
showed a large increase in visible absorbing species over that 
produced with the heat-inactivated preparation; with GDHB as 
substrate, however, little difference was observed between in-
cubation with active and heat-inactivated melanosomes (Fig 3). 
Thus, an enzymatic system specific for the oxidation of L-
DOP A was present in these melanosome preparations. In ad-
dition to an enzyme-specific oxidation of 1-DOPA, both L-
DOPA and GDHB underwent nonenzymatic oxidation in so-
lution, since with the heat-inactivated melanosome prepara-
tions some visible absorbing species appeared upon incubation. 
These results indicated that, even if hydroxylation of GHB to 
GDHB were to take place, the subsequent oxidation of GDHB 
would proceed only at the low rate of a nonenzymatic reaction. 
y-Glutamyl Transpeptidase 
The lack of significant activation of GHB and GDHB by 
mammalian tyrosinase prompted the investigation of potential 
alternate routes for the generation of melanocytotoxic activity 
from this compound. Crude porcine kidney GGTP was incu-
bated with various concentrations of GHB in pH 8.0 buffer of 
50 mM Tris-HCl and 75 mM NaCl at 30°C in the presence of 50 
mM glycylglycine as an amino acid acceptor. The cleavage 
product p-aminophenol was observed by following the appear-
ance of its 294 nm chromophore. The enzymatic activity with 
GHB was compared to that of a commonly used y-glutamyl 
compound, y-1-glutamyl-4-nitroaniline. Shown in Fig 4 is a 
double reciprocal plot of the velocity of the GGTP reaction 
versus GHB concentration, giving a Km = 1.65 mM and a V mnx 
= 1.83 ~-tmoles/min/mg of protein. Reactions run under identical 
conditions with y-1-glutamyl-4-nitroaniline as substrate gave a 
Km = 0.85 mM and Vmnx = 8.27 f.tmoles/min/mg of protein. GHB 
was also found to be a competitive inhibitor of the GGTP 
reaction when y-1-glutamyl-4-nitroaniline was used as sub-
strate. Thus, GHB was a substrate for GGTP, and its rate of 
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Frc 2. The reaction of GHB and mammalian tyrosinase with GDHB 
or L-DOPA as co-factor. Active and heat-inactivated melanoma prep-
arations, similar to those described in the Table, were reacted with 0.51 
mM GHB and 0.1 mM d.ihydroxy co-factor in 5 mM sodium phosphate 
buffer pH 7.2 at 30°C. Reaction aliquots of 100 ,.U were wi thdJ·awn, 
added to a charcoal suspension and tritium water release determined 
[4]. Activity is expressed as nmoles of tritium water (3HOH) released 
in the reaction volume of 1.1 mi. Tritium label was present at 11.1 dpm/ 
pmol. 
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cleavage was similar to that of many of the natural substrates 
for this enzyme [22]. 
M eGHB was synthesized to provide a compound identical to 
GHB except for the presence of a methyl group attached to the 
nitrogen of the amide linkage. Methylation of amide linkages is 
known to inhibit proteolytic cleavage [38]. The rate of reaction 
of GGTP with 1.0 mM M eGHB in pH 8.0 buffer of 50 mM Tris-
HC1 and 75 mM NaCl with 50 mM g1yclyg1ycine is an amino 
acid acceptor was only 2% of that found with 1.0 mM GHB 
under the same conditions. Modification of GHB by methyla-
tion of the amide linkage therefore resulted in a compound 
resistant to cleavage by GGTP. 
M elanocytotoxicity of p -aminophenol and MeGHB 
The cleavage product from the GGTP reaction with GHB is 
p -aminophenol, a compound structurally and chemically similar 
to both hydroquinone and p-phenylenediamine. Hydroquinone 
was among the best depigmenting agents of 300 compounds 
tested by Chavin [18]. p-Phenylenediamine has been investi-
gated as a potential chemotherapeutic agent against experinlen-
tal melanoma [39]. Both of these compounds exhibit melano-
cytotoxic effects. 
The melanocytotoxic activity of p-aminophenol was fu·st 
tested by observing depigmentation of the hair of black mice. 
Five-week-old C57Bl/6J mice were injected intraperitoneally 
with 50, 100, 200 and 400 mg/ kg p -aminophenol. All animals 
s howed characteristic symmetrical loss of pigment from growing 
hair [17]. The higher the dose, t he more extensive was the 
quantity of hair depigmented. p-Aminophenol was thus deter-
mined to be an active depigmenting agent. GHB, in comparison, 
was reported to induce depigmentation in adult C57Bl/6J mice 
at 400 mg/ kg [1]. To confu·m the melanocytotoxic activity ofp-
aminophenol, 10 neonatal C57Bl/6J mice were injected with 
400 mg/kg p-aminophenol; at 12, 24, 48 and 96 hr after injection 
2 animals were sacrificed and skin from the head was prepared 
L - DOPA GDHB 
0.1 
..................... 
........ 
......... 
.......... 
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-------
Q L----'----'--......__ _ __, L--L----'---:-'--..J 
450 500 450 
Wavelength ( nm) 
FIG 3. ·Oxidation of L-DOPA and GDHB by active and heat-inacti-
vated tyrosinase. Purified melanosomes [27], active and heat-inacti-
vated by boiling for 15 min, were incubated with 1.0 mM L-DOPA or 
1.0 mM GDHB in 0.1 M sodium phosphate buffer, pH 7.4 for 45 min at 
37°C. Following the incubation, the reaction solution was centrifuged 
at 10,000 xg for 10 min and the supernatant scanned from 400 to 600 
nm using a Cru·y 219 spectrophotometer. --active enzyme;--- heat-
inactivated enzyme. 
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0 2 3 4 
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FIG 4. A double reciprocal plot of the reaction of GGTP with GHB. 
The reaction was followed spectrophotometrically by observing the 
appearance of the 294 nm chromophore of the released p-aminophenol. 
Crude porcine kidney GGTP (60 /Lgm protein) was added to vru·iable 
concentrations of GHB to initiate the reaction in pH 8.0 buffer at a 
final concentration of 50 mM Tris-HCl, 75 mM NaCl and 50 mM 
glycylglycine at 30°C in a final volume of 1.0 ml.The least-squares fit is 
shown with a correlation coefficient of 0.99. The appru·ent V,., = 1.83 
/Lmoles/min/ mg protein and the K, = 1.65 mM. 
for microscopy. By 12 h.r following injection, the melanocytes 
present in hair follicles showed marked swelling and karyolysis, 
consistent with irreversible cell injury. In the basilar segment 
of the follicles, condensed bodies containing cellular debris were 
seen. Other cellular elements of the follicle appeared normal 
and included actively dividing keratinocytes. These changes are 
identical to those earlier found with GHB [17] and represent 
the morphologic evidence of a melanocytotoxic response to p-
aminopheno1. By 24 hr, many of the hair follicles were devoid 
of melanocytes. The 2 animals not sacrificed showed complete 
depigmentation of their newly grown hair by 10 days after 
treatment. 
MeGHB differed from GHB by resistance to cleavage by 
GGTP. No depigmentation of the hair occurred at doses of 400, 
800 or 1200 (cumulative) mg/kg MeGHB injected subcutane-
ously into neonatal C57Bl/6J mice. The hair follicles 12 hr after 
injection with 800 mg/ kg MeGHB appeared normal morpho-
logically. T he melanocytes were intact and showed no evidence 
of swelling or injury. These findings were in marked contrast to 
those obtained following injection of p-aminophenol, as de-
scribed above, or GHB [17]. Thus, the structural modification 
of GHB conferring immunity to cleavage by GGTP was accom-
panied by a loss of melanocytotoxic activity, as evidenced by 
the lack of depigmentation and the normal appearance of hair 
follicles following the injection of MeGHB. 
DISCUSSION 
Melanocytes are unique cells biochemically because of the 
presence of melanosomes. These complex organelles consist of 
tyrosinase and melanin organized into a subcellulru· structw·e 
[ 40]. Melanocytes ru·e pru:ticulru·ly susceptible to toxicity from 
many compounds. A perturbation of normal melanogenesis, as 
with the increased MSH stimulation observed in adrenocortical 
insufficiency, can render the melanocyte vulnerable to injmy 
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[ 41,42]. Exobiotic substances can also cause melanocytotoxicity. 
The mechanism by which exobiotic compounds act on the 
melanocyte remains uncertain, though many potential routes 
of interaction have been offered [19]. Activation to cytotoxic 
agents by tyrosinase h as been proposed [2]. Many of the me-
lanocytotoxic exobiotic compounds are easily oxidized; thus, a 
nonenzymatic interaction with oxidized elements of the mela-
nosome may lead to their oxidation. Once oxidized, increased 
nucleophilic reactivity (with sulfhydryl groups, for example) 
might then account for the cytotoxic effects observed. Whatever 
the mechanism of activation, t he ability of many compounds to 
cause specific melanocyte toxicity as evidenced by depigmen-
tation has encouraged investigators to test these compounds 
against melanocarcinomas. The phenylenediamines [39], h y-
droquinone [18], monoethyl ether of hydroquinone [43], 4-iso-
propylcatechol [ 44], L-DOPA methyl ester [ 45], dopamine [ 46] 
and GHB [1,2] have all been tested as ch emotherapeutic agents. 
In general, t he results from treating melanomas have been 
disappointing; compounds which specifically destroy epidermal 
and follicular melanocytes at most delay the growth of experi-
mental melanoma. The reasons for this differential response 
are obscure; however, this observation does suggest that tyro-
sinase levels per se (which m ay be very high in tumor cells) do 
not predict the cytotoxic response. 
Enzymatic reaction with mammalian tyrosinase has been 
proposed as the mechanism for generating cytotoxic compounds 
from GHB [2]. In this study, we utilized [3,5-3H]GHB to deter-
mine the hydroxylating activity of B16 melanoma tyrosinase 
with GHB. GHB was hydroxylated at 25% of the rate of 
tyrosine, releasing tritium water only in th e presece ofL-DOPA, 
but not GDHB, as co-factor. These results support th e presence 
of a tyrosine-specific mammalian hydroxylating system (mam-
malian tyrosinase), in the continuing controversy over the ex-
istence of such an enzymatic capability [ 47]. On the other hand, 
the label release observed with GHB could be due to nonenzy-
matic or peroxidase-catalyzed reactions with "activated oxy-
gen" or to mammalian tyrosinase hydroxylation with L-DOPA 
as co-factor. GDHB, th e product resul ting from hydroxylation 
of GHB, was not a substrate for tyrosinase. This suggested that 
the enzymatic activation of GHB to quinones found in the 
mushroom does not occur to a significan t degree in mammalian 
cells containing tyrosinase. 
An alternate mechanism of activation of GHB via GGTP 
cleavage was therefore explored. The greatest concentration of 
GGTP is found in the luminal portion of cells of the proximal 
convoluted tubules of the kidney [48-50]. y-Glutamyl com -
pounds undergo a rapid preliminary cleavage of the y-glutamyl 
amide bond primarily in the kidney prior to re-distribution of 
the cleavage products to other tissues [51,52]. GHB was found 
to be a good substrate for GGTP releasing p-aminophenol as a 
product. p-Aminophenol was shown to be an active depigm ent-
ing agent. Microscopic evidence of irreversible injury to m ela-
nocytes in hair follicles was obtained following th e injection of 
p-aminoph enol. MeGHB, differing from GHB only by the pres-
ence of a methylated amide bond, was not a significant substrate 
for GGTP. Following injection of MeGHB, no morphologica l 
changes were observed in the melanocytes of hair follicles nor 
was depigmentation observed. We therefore postulate that pre-
liminary cleavage of GHB by GGTP to release p-aminophenol 
is required for melanocytoxicity. 
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